Search

everythinglearnresearchcommunity

for

Search:↓

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A specific genetic deletion in goats affects cashmere yield and thickness.

Three compounds from Dadap leaves may help treat hair loss.

Oral JAK inhibitors help regrow hair in alopecia patients.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Procyanidin compounds from grape seeds were found to significantly increase mouse hair growth.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Finasteride improves hair growth in men with androgenetic alopecia.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride reduces new brain cells in male mice, possibly causing depression.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Testosterone's muscle-building effects do not require its conversion to DHT.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Baricitinib is effective and safe for treating severe alopecia areata.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.